Background
==========

The chemical sensory systems mainly consist of olfactory sensation, gustatory sensation and trigeminal nerves. Although these 3 chemical sensory systems are regulated independently in daily life, they work together collaboratively \[[@b1-medscimonit-18-3-cr154]--[@b3-medscimonit-18-3-cr154]\]. Regulation of intranasal chemical sensory signals is mainly accomplished through the olfactory nerve and trigeminal nerves \[[@b4-medscimonit-18-3-cr154]\], while gustatory sensation during eating relies on a high level of integration of the olfactory, gustatory and trigeminal signals \[[@b2-medscimonit-18-3-cr154],[@b5-medscimonit-18-3-cr154]\]. Loss or reduction of olfactory and gustatory sensation is the most common type of dysosmia and dysgeusia \[[@b6-medscimonit-18-3-cr154]\]. Because odor discrimination largely relies on olfactory sensation \[[@b7-medscimonit-18-3-cr154]\], physicians should not only examine hypogeusia but also investigate potentially concomitant hyposmia when subjects complain about tasteless food. Currently, the common methods used in clinical laboratories include olfactory event-related potentials (oERPs) \[[@b8-medscimonit-18-3-cr154]\] and T&T olfactometer \[[@b9-medscimonit-18-3-cr154]\] for olfactory examination, trigeminal event-related potentials (tERPs) \[[@b10-medscimonit-18-3-cr154]\] for trigeminal nerve examination, and triple drop method for gustatory examination \[[@b11-medscimonit-18-3-cr154]\]. The purpose of the present study was to exam 272 subjects using the above methods to investigate changes of the chemical sensory functions in patients with dysosmia in a Chinese population.

Material and Methods
====================

Subjects
--------

This retrospective study enrolled 272 subjects, with 98 in a healthy group including 50 men and 48 women of 18--70 years of age and mean age of 40±13 years. The subjects were divided into 3 subgroup: 34 in the younger group (18--35 years of age), 33 in the middle-age group (36--50 years of age), and 31 in the older group (51--70 years of age). The 86 subjects in the hyposmia group including 45 men and 41 women of 14--72 years of age and mean age of 41±15 years; and these were also divided into 3 subgroups: 26 in the younger group, 36 in the middle-age group, and 24 in the older group. The 88 subjects in the functional anosmia group included 43 men and 45 women of 18--71 years of age and mean age of 42±11 years; and these were divided into 3 subgroups: 19 in the younger group, 42 in the middle-age group, and 27 in the older group ([Table 1](#t1-medscimonit-18-3-cr154){ref-type="table"}). All healthy volunteers were from the Department of Physical Examination and had no chief complaints of dysosmia and dysgeusia, abnormal nasoendoscopic findings, or other body discomforts or medical history of chemical sensory system disorders. The 174 patients with dysosmia included 91 with chronic sinusitis and nasal polyps, 29 with dysosmia after upper respiratory tract infection, 32 with post-traumatic dysosmia, 6 with congenital anosmia and 16 with dysosmia of unknown causes, and all these subjects were from the outpatient clinic of the Department of Otolaryngology-Head and Neck Surgery between 2007 and 2011. These patients were entered the study consecutively at admission and were allocated into hyposmia group and anosmia group according to clinical diagnostic results. The entire study protocol had been approved by the ethics committee of the hospital and subjects understood these examinations and signed the informed consent forms before initiation of any study-related procedures.

Chemosensory assessment
-----------------------

### T&T olfactometer

T&T olfactometer was purchased from Daiichi Pharmaceutical Co. Ltd. (Japan). Standard administration was performed according to the manufacturer's instructions. Briefly, quantitative analysis was based on the dilution time of 5 odorants (rose, scorched, rotten, fruit and stool), each substance at 8 concentrations (10^2^\~10^5^) which represented 8 degrees (−2 to +5). Average odor threshold, which was obtained by dividing the sum of identification threshold for 5 olfactory substances by 5, was used to judge the degree of olfactory injury \[[@b9-medscimonit-18-3-cr154]\].

### oERPs and tERPs

Both exams were performed using published protocols. Phenethyl alcohol was purchased from J&K Chemical Reagent Company (Beijing). The Olfactometer OM6b was purchased from Burghart (Germany). Briefly, the subjects were in the sitting position comfortably, relaxed, and were asked to sit still, to neither blink nor swallow, and to breathe through the mouth. Olfactory and trigeminal stimuli (40%v/v Phenethyl alcohol and 40% v/v CO2, respectively) were infused to the olfactory field of the nasal cavity at a constant temperature and flow rate. The infusion of each gas was repeated for 30 times alternatively (stimulus duration: 250ms, interval: 30s, flow rate: 8L/min). The whole operation was performed in a well ventilated and electrically shielded room. Brain potentials were recorded at Fz, Cz, Pz, C3, and C4, etc. on the scalp according to international standard 10/20 method. Generally, the waveform recorded at Cz was the best. Reference electrodes were placed at the left and right ear lobes (A1 and A2). Stable oERPs and tERPs waveforms were obtained after amplification and filtering. Records contaminated by blinking were excluded. During the examination, white noise of 60 dB was presented via a head phone to mask the interference noise \[[@b8-medscimonit-18-3-cr154],[@b10-medscimonit-18-3-cr154]\].

### Gustatory function by the triple drop method

Subjective examination of gustatory function was performed using the triple drop method. Sucrose, sodium chloride, citric acid and quinine hydrochloride were purchased from Chemical Reagent Company (Beijing). We prepared solutions of different concentrations of each tastant; the lowest concentrations of sucrose, sodium chloride, citric acid and quinine hydrochloride were 0.19 g/mL, 0.06 g/mL, 0.15 g/mL and 0.0012 g/mL, respectively. The subjects were not allowed to eat 1 h before the examination. When performing the examination, 1 drop of the above solutions and 2 drops of distilled water were placed on the anterior 1/3 of the tongue in randomized order. After closing the mouth, the subjects were asked to identify the taste as sweet, sour, salty, or bitter, and to rinse the mouth with water. Bitterness was tested at the end of the session. If a subject chose the wrong answer, then a higher concentrated solution was used for the next trial. Total score was obtained by the sum of 4 tastents' result \[[@b11-medscimonit-18-3-cr154]\].

Statistical analysis
--------------------

All analyses were performed using SPSS12.0. The results of T&T, triple drop method, latencies and amplitude of each wave in ERPs were expressed as mean ±SD. Normal distribution test was performed on the data in each group and test of homogeneity of variance was performed on grouping data, then differences in average between different groups were analyzed using one-way ANOVA. The post-hoc multiple comparisons test was employed to analyze the differences between individual groups. Pearson statistics were used for correlation analyses between different tests.

Results
=======

T&T olfactometer
----------------

For T&T examination, the results showed that the difference between patients with hyposmia and functional anosmia and healthy subjects had statistical significance (P=0.001, 0.001, respectively). There was a significant difference between the hyposmia group and the functional anosmia groups (P=0.001). For the younger group there were significant differences between healthy subjects and patients with hyposmia and functional anosmia. (P=0.001, 0.001, respectively). The results are shown in [Table 1](#t1-medscimonit-18-3-cr154){ref-type="table"}.

oERPs
-----

The result of oERPs showed that there was significant difference in latencies of the N1 peak between healthy subjects and hyposmia group/functional anosmia group (P=0.001, 0.001, respectively), and there was also significant difference in amplitude of N1 wave between healthy subjects and the functional anosmia group (P=0.001). For P2 wave, there was significant difference in latencies between healthy subjects and the hyposmia group/functional anosmia group (P=0.044, 0.043 respectively), and there was also significant difference in amplitude of P2 wave between healthy subjects and the functional anosmia group (P=0.009). For the younger group, there was significant difference in latencies of N1 peak between healthy subjects and patients with hyposmia (P=0.045). The results are shown in [Table 1](#t1-medscimonit-18-3-cr154){ref-type="table"}.

tERPs
-----

The result of tERPs showed that there was significant difference in latencies of the N1 peak between healthy subjects and hyposmia group/functional anosmia group (P=0.001, 0.001 respectively). For P2 wave, there was significant difference in latencies between healthy subjects and functional anosmia group (P=0.001), and there was also significant difference between hyposmia group and functional anosmia group (P=0.004). There was significant difference in amplitude of P2 wave between healthy subjects and hyposmia group (P=0.01). For the younger group, there were significant difference in latencies of N1 peak between healthy subjects and hyposmia group/functional anosmia group (P=0.027, 0.003), and there was also significant difference in latencies of P2 peak between healthy subjects and patients with functional anosmia group (P=0.019). The results are shown in [Table 2](#t2-medscimonit-18-3-cr154){ref-type="table"}.

Correlations analysis
---------------------

For correlations between olfactory tests, measures of olfactory function were correlated with parameters of oERPs and T&T. The T&T results were significantly correlated with latencies of N1/P2 (N1r=0.412, P=0.001; P2r=0.250, P=0.001) and amplitudes of N1/P2 peak (N1r=−0.218, P=0.001, P2r=−0.230, P=0.001), indicating that lower T&T result were generally associated with shorter latencies of N1/P2 and higher amplitudes of P2 peak. The oERPs and tERPs was significantly correlated with latencies of N1/P2 (N1r=0.510, P=0.001, P2r=0.309, P=0.001) and amplitudes of N1 peak (N1r=0.321, P=0.001). The trigeminal N1/P2 latencies were earlier than olfactory N1/P2 (P~N1~=0.001, P~P2~=0.001), and the trigeminal N1/P2 amplitude were greater than olfactory N1/P2 (P~N1~=0.001, P(~P2~=0.001).

Three drops method
------------------

Gustatory function examination showed that there was significant difference between healthy subjects and the functional anosmia group (P=0.036). The results are shown in [Table 3](#t3-medscimonit-18-3-cr154){ref-type="table"}.

Discussion
==========

Our T&T result showed significantly decreased olfactory function in comparing patients to healthy subjects, and similar trends were observed in the Ishimaru et al. \[[@b9-medscimonit-18-3-cr154]\] study. T&T examination is sensitive to the smell loss of Japanese sinusitis/polyposis patients \[[@b12-medscimonit-18-3-cr154]\] and has been used as a "subjective" examination of olfactory function in Chinese clinics for many years. Our study confirmed it is a reliable method to divide subjects with euosmia from those with anosmia. Up to now, the oERPs test as an "objective" examination of olfactory function has not been widely used in clinical examination in China, but often was used in animal research \[[@b13-medscimonit-18-3-cr154]\]. Our data showed that postponed latency and reduced amplitude of N1 and P2 waves of oERPs were observed in patients with functional anosmia in this study when compared to healthy subjects; the results demonstrated clear changes in oERPs under dysosmia and suggest a possible application of this method in clinical diagnosis in Chinese populations. Braemerson et al. \[[@b14-medscimonit-18-3-cr154]\] showed that patients with dysosmia had prolonged latency and reduced amplitude of oERPs when compared to healthy subjects. Similar trends were observed in our study. Lotsch et al. \[[@b15-medscimonit-18-3-cr154]\] detected oERPs using phenethanol as a stimulant in 123 subjects and demonstrated the potential to differentiate patients with euosmia from those with anosmia using the oERPs technique in a European population.

Studies have demonstrated a correlation between objective (oERPs) and subjective (T&T) olfactory examination methods. Lower T&T values correlate with shorter latency and higher amplitude of N1 and P2 waves. In a study involving 88 patients with functional anosmia, the T&T values were all greater than 5.5 and oERPs was detectable in 20 patients (detection rate: 22%). The T&T result meant that a portion of patients with anosmia still retained some olfactory function. In this study, the results were interpreted by the following criteria: subjects had normal olfactory function if T&T results were normal and oERPs were detectable at the same time; subjects had functional anosmia if T&T results indicated anosmia and oERPs were undetectable at the same time; subjects might have hyposmia if T&T results indicated hyposmia and oERPs were undetectable, possibly because detection of oERPs was interfered with by blinking movement or hyperactivity of facial muscles during examination; subjects still had olfactory function if T&T results indicated functional anosmia and oERPs were detectable. Ishimaru et al. \[[@b9-medscimonit-18-3-cr154]\] examined 14 patients using T&T and EOEP methods and observed a T&T value greater than 5.8 in 1 patient with detectable EOEP. Lötsch et al. \[[@b15-medscimonit-18-3-cr154]\] also observed detectable oERPs in 20% of patients with functional anosmia, a result consistent with ours. This study indicated combined subjective and objective examination would better reflect olfactory function with patients.

Our study findings show that patients with hyposmia or anosmia had reduced amplitude and postponed latency of N1 and P2 waves of tERPs when compared to healthy subjects. Consistent with Hummel's conclusion \[[@b16-medscimonit-18-3-cr154]\], this observation also suggests that trigeminal nerve functions were affected in European patients with dysosmia. The olfactory and trigeminal pathways are concentrated in identical neural units of the mediodorsal thalamic nucleus. The trigeminal system and olfactory system interact with each other in the central nervous system. It was shown by comparing functional imaging of trigeminal and olfactory conduction that these 2 chemical sensory systems are independent of each other, but are closely interrelated \[[@b17-medscimonit-18-3-cr154]--[@b19-medscimonit-18-3-cr154]\]. When interaction between these 2 systems at nerve centers in the brain was lost in anosmia, sensitivity of intranasal trigeminal nerves subsequently decreased \[[@b20-medscimonit-18-3-cr154]\]. Our data show that olfactory and trigeminal function of younger subjects of olfactory dysfunction were clearly decreased to compare with healthy subjects. The olfactory and trigeminal function of patients in the middle-age group and the old-aged group was generally lower than in healthy subjects, but there was no statistical significance. The results were consistent with report by Frasnelli \[[@b21-medscimonit-18-3-cr154],[@b22-medscimonit-18-3-cr154]\] who showed that persistent dysosmia decreased sensitivity of the trigeminal nerves. However, such effect was weak or difficult to detect in mostly elderly patients \[[@b23-medscimonit-18-3-cr154]\]. Sensitivity of intranasal trigeminal nerves could be improved with recovery of olfactory functions \[[@b24-medscimonit-18-3-cr154]\]. Murphy et al. \[[@b25-medscimonit-18-3-cr154]\] showed that the latency of N1 and P2 waves of oERPs was 30--70 ms earlier than that of tERPs; in contrast, N1 and P2 amplitudes of tERPs were higher than that of oERPs in an American population. In our study, we observed that the latency and amplitude of tERPs were earlier and higher than that of oERPs, respectively, with differences of statistical significance. The result was comparable with reports by Stuck \[[@b26-medscimonit-18-3-cr154]\] and Welge-Lussen \[[@b27-medscimonit-18-3-cr154]\]. This may suggest that the human cerebral cortex responds more slowly to olfactory stimulus than to trigeminal stimulus, and interaction between olfactory system and trigeminal system may take place at the subcortical level. Despite involvement in the perception of chemicals, the intranasal trigeminal system has received relatively little attention compared to the olfactory system in China. This study provides further evidence that tERPs is a sensitive and specific method, and olfactory status could influence sensitivity of the intranasal trigeminal system.

Three drops test comes from Germany; until now this test has not been used in clinical examination in China. Overall, our results show that these tests are feasible in Chinese populations. Some reports indicated that gustatory functions decrease somewhat with aging \[[@b11-medscimonit-18-3-cr154]\]. We divided the subjects into different subgroups according to age, and there was no significant difference between individual groups. This indicates that decreasing of gustatory function exhibited little or no relationship with age and is in agreement with our previous work \[[@b28-medscimonit-18-3-cr154]\]. This study demonstrated that patients with functional anosmia manifested significant hypogeusia when compared to healthy subjects. The results were consistent with a report by Landis \[[@b1-medscimonit-18-3-cr154]\], who examined 107 healthy subjects and 103 patients with dysosmia. They observed that patients with long-term olfactory impairment manifested dysgeusia and suggested that interaction between chemical sensory systems were characterized by mutual attenuation rather than compensation. Vennemann \[[@b29-medscimonit-18-3-cr154]\] showed that hypogeusia was often accompanied by olfactory impairment, and interaction between chemical sensory systems resulted in simultaneous functional impairment. Kettenmann \[[@b30-medscimonit-18-3-cr154]\] showed that N1 and P2 waves were very useful in examining the correlation between olfactory and gustatory functions because both of them were generated in the insular cortex. There was close interaction between olfactory and gustatory neural centers \[[@b31-medscimonit-18-3-cr154]\]. Such interaction possibly took place at the subcortical level and manifested the characteristic of mutual amplification. Clinically, anosmia corresponded with alteration of gustatory threshold \[[@b27-medscimonit-18-3-cr154]\]. This observation suggests that chemical sensory functions are interrelated and interact with each other. Impairment of 1 sensory function will affect the other 2. Because of continuous and repetitive interactions in daily life, functions of the 3 chemical sensory systems are interrelated \[[@b32-medscimonit-18-3-cr154]\]. Sudden loss of 1 chemical sensation in patients will lead to the absence of the afferent signals, and further decrease the integrated reaction of the remaining 2 chemical sensory systems \[[@b16-medscimonit-18-3-cr154],[@b23-medscimonit-18-3-cr154]\].

Conclusions
===========

Our data show that patients with functional anosmia often had significant trigeminal nerve dysfunction and hypogeusia. Especially in younger patients, demonstrated olfactory and trigeminal function clearly decreased. These findings will be useful for assessing chemosensory function in future work in Chinese populations, particularly when assessing subjects with olfactory complaints and olfactory disease. Combined examinations of T&T oERPs, tERPs and three drops method will make it possible to reflect the overall chemical sensory functions in subjects systematically, and to provide scientific evidence for early clinical diagnosis and treatment.
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###### 

Descriptive statistics of T&T olfactometer and Olfactory event-related potentials.

  Group                Age      Number   T&T                                                                 N1-latencies(ms)                                                 N1-amplitude(uv)                                                   P2-latencies(ms)                                                 P2-amplitude(uv)                                                   
  -------------------- -------- -------- ------------------------------------------------------------------- ---------------------------------------------------------------- ------------------------------------------------------------------ ---------------------------------------------------------------- ------------------------------------------------------------------ -----------
  Healthy              Young    18--35   34                                                                  −1.55±0.59                                                       375±70                                                             −4.59±1.67                                                       565±80                                                             7.42±4.19
  Middle age           36--50   33       −1.16±0.91                                                          434±123                                                          −4.70±2.00                                                         618±138                                                          6.83±3.88                                                          
  Old-age              51--70   31       −0.87±0.94                                                          465±96                                                           −4.67±2.52                                                         664±113                                                          6.44±3.20                                                          
  Total                         98       −1.21±0.86[\*](#tfn2-medscimonit-18-3-cr154){ref-type="table-fn"}   423±104[\*](#tfn2-medscimonit-18-3-cr154){ref-type="table-fn"}   4.65±2.06[\*](#tfn2-medscimonit-18-3-cr154){ref-type="table-fn"}   614±119[\*](#tfn2-medscimonit-18-3-cr154){ref-type="table-fn"}   6.91±3.78[\*](#tfn2-medscimonit-18-3-cr154){ref-type="table-fn"}   
  Hyposmia             Young    14--35   26                                                                  1.50±2.16                                                        544±200                                                            −4.58±3.99                                                       674±179                                                            6.73±5.76
  Middle age           36--50   36       1.73±2.17                                                           575±224                                                          −3.64±3.51                                                         677±221                                                          4.84±2.75                                                          
  Old-age              51--72   24       3.07±2.05                                                           580±146                                                          −3.35±3.30                                                         713±155                                                          6.12±3.60                                                          
  Total                         86       2.04±2.21[\*](#tfn2-medscimonit-18-3-cr154){ref-type="table-fn"}    565±197[\*](#tfn2-medscimonit-18-3-cr154){ref-type="table-fn"}   3.91±3.61                                                          684±190[\*](#tfn2-medscimonit-18-3-cr154){ref-type="table-fn"}   5.81±4.25                                                          
  Functional anosmia   Young    18--35   19                                                                  5.64±0.26                                                        447±139                                                            −3.98±3.63                                                       597±142                                                            5.41±3.26
  Middle age           36--50   42       5.54±1.67                                                           580±188                                                          −3.01±1.75                                                         701±171                                                          4.93±3.86                                                          
  Old-age              51--71   27       5.64±0.21                                                           672±243                                                          −1.75±1.48                                                         791±236                                                          4.62±2.83                                                          
  Total                         88       5.59±0.49[\*](#tfn2-medscimonit-18-3-cr154){ref-type="table-fn"}    571±197[\*](#tfn2-medscimonit-18-3-cr154){ref-type="table-fn"}   3.02±2.43[\*](#tfn2-medscimonit-18-3-cr154){ref-type="table-fn"}   691±187[\*](#tfn2-medscimonit-18-3-cr154){ref-type="table-fn"}   5.00±3.28[\*](#tfn2-medscimonit-18-3-cr154){ref-type="table-fn"}   

Results are shown as mean ±SD.

P\< 0.05.

###### 

Descriptive statistics of trigeminal event-related potentials.

  Group                Age      Number   N1-latencies(ms)                                                 N1-amplitude(uv)   P2-latencies(ms)                                                 P2-amplitude(uv)                                                    
  -------------------- -------- -------- ---------------------------------------------------------------- ------------------ ---------------------------------------------------------------- ------------------------------------------------------------------- ------------
  Healthy              Young    18--35   34                                                               320±37             −6.82±3.47                                                       476±64                                                              9.36±4.12
  Middle age           36--50   33       343±64                                                           −5.83±2.66         518±100                                                          7.62±2.83                                                           
  Old-age              51--70   31       384±96                                                           −5.35±4.45         574±93                                                           6.46±3.79                                                           
  Total                         98       348±73[\*](#tfn4-medscimonit-18-3-cr154){ref-type="table-fn"}    6.02±3.60          521±95[\*](#tfn4-medscimonit-18-3-cr154){ref-type="table-fn"}    7.85±3.78[\*](#tfn4-medscimonit-18-3-cr154){ref-type="table-fn"}    
  Hyposmia             Young    14--35   26                                                               426±129            −5.56±7.70                                                       552±117                                                             11.80±7.68
  Middle age           36--50   36       406±129                                                          −5.99±6.24         547±121                                                          9.83±5.52                                                           
  Old-age              51--72   24       436±114                                                          −6.01±5.49         597±109                                                          9.45±5.37                                                           
  Total                         86       421±125[\*](#tfn4-medscimonit-18-3-cr154){ref-type="table-fn"}   5.85±6.52          560±117                                                          10.39±6.28[\*](#tfn4-medscimonit-18-3-cr154){ref-type="table-fn"}   
  Functional anosmia   Young    18--35   19                                                               442±101            −6.58±7.75                                                       586±107                                                             10.96±6.20
  Middle age           36--50   42       431±107                                                          −5.11±4.16         601±152                                                          9.61±6.20                                                           
  Old-age              51--71   27       551±180                                                          −3.88±2.35         680±175                                                          7.70±5.05                                                           
  Total                         88       464±135[\*](#tfn4-medscimonit-18-3-cr154){ref-type="table-fn"}   5.22±5.15          616±150[\*](#tfn4-medscimonit-18-3-cr154){ref-type="table-fn"}   9.50±6.05                                                           

Results are shown as mean ±SD.

P\< 0.05.

###### 

Descriptive statistics of triple drop test.

  Group                Age      Number   Three drops test                                                    
  -------------------- -------- -------- ------------------------------------------------------------------- ------------
  Healthy              Young    18--35   34                                                                  36±0
  Middle age           36--50   33       35.97±0.17                                                          
  Old-age              51--70   31       35.97±0.18                                                          
  Total                         98       35.98±0.14                                                          
  Hyposmia             Young    17--35   26                                                                  35.62±1.96
  Middle age           36--50   36       35.63±1.45                                                          
  Old-age              51--72   24       35.38±1.55                                                          
  Total                         86       35.56±1.62                                                          
  Functional anosmia   Young    18--35   19                                                                  35.37±2.29
  Middle age           36--50   42       34.48±5.83                                                          
  Old-age              51--71   27       34.81±2.71                                                          
  Total                         88       34.77±4.40[\*](#tfn6-medscimonit-18-3-cr154){ref-type="table-fn"}   

Results are shown as mean ±SD.

P\< 0.05.
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